About Bond Biosciences
Bond Biosciences is a private company based in Parkville, Missouri. It has reported $24,125,536 raised in five offerings on Form D since September 2020.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 1, 2026 | Apr 8, 2026amended Oct 5, 2026 | $7,614,879of $15.0M target | 122 | $62,417 | EquityRule 506(b) | Form D/A ↗2 earlier filings |
| Aug 22, 2024 | Sep 6, 2024amended Jan 29, 2026 | $4,500,000fully sold | 91 | $49,451 | Simple Agreement for Future EquityRule 506(b) | Form D/A ↗4 earlier filings |
| Dec 17, 2021 | Jan 3, 2022 | $6,810,666of $10.0M target | 81 | $84,082 | EquityRule 506(b) | Form D ↗ |
| Oct 23, 2020 | Nov 4, 2020amended Dec 8, 2020 | $4,999,991of $6.0M target | 57 | $87,719 | Equity, Options, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Aug 31, 2020 | Sep 14, 2020 | $200,000fully sold | 8 | $25,000 | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Total, five offerings | $24,125,536 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Bond Biosciences's Form D filed Oct 5, 2026.
MB
Michael Beckloff
Director
TO
Timothy Opler
Director
Michael Riley
Executive officer and director
JS
Jay Shepard
Director
Sources
- SECBond Biosciences, Inc. Form D/A, filed Jun 4, 2026
- SECBond Biosciences, Inc. Form D, filed Apr 8, 2026
- SECBond Biosciences, Inc. Form D/A, filed Dec 8, 2025
- SECBond Biosciences, Inc. Form D/A, filed Oct 22, 2025
- SECBond Biosciences, Inc. Form D/A, filed Sep 24, 2024
- SECBond Biosciences, Inc. Form D, filed Sep 6, 2024
- SECBond Biosciences, Inc. Form D, filed Nov 4, 2020
- SECBond Biosciences, Inc. filing history
- CompanyTerms of use
- CompanyLeadership